Federal Funding Opportunities

Winship investigators have access to an extensive listing of cancer-related funding issued by the National Institutes of Health and other federal agencies. The listing updates automatically on a daily basis.

Use the column sorting, search filtering, and pagination tools to find and select federal funding opportunities below.

Cascade Link
OpportunityPostedClosing

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/11/2201/07/25

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINIAMSNIDCR

01/11/2201/07/25

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)

Agency: NIH

Institutions: NICHDNEINHLBINHGRINIANIAAANIDCDNIDANIMHNINDSNINRNIMHDNCI

01/10/2201/07/25

Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 - Clinical Trials Optional)

Agency: NIH

Institutions: NIMHDNEINIANIAMSNIDCDNIDANINRNCIORWH

01/10/2209/07/24

HEAL Initiative: National K12 Clinical Pain Career Development Program (K12 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNIANICHDNIDCRNCCIHNCI

01/10/2203/24/22

HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNIANIAAANIAMSNICHDNIDCRNIDDKNCCIHNCATSNCI

01/07/2212/06/24

Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCATSNIANIAAANIAMSNIDCRNIDANINDSNCCIHNCIORWH

01/06/2205/01/23

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/03/2209/22/22

Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/03/2209/22/22

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)

Agency: NIH

Institutions: NCI

01/03/2209/22/22

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/03/2209/22/22

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/03/2209/22/22

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/03/2209/22/22

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/03/2209/22/22

U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional)

Agency: NIH

Institutions: NCIFIC

01/03/2203/30/22

Technical Assistance Towards Strengthening Faith Based Organizations (FBOs) in Achieving Comprehensive HIV/AIDS/TB/STI Prevention, Care and Treatment Services in Zambia under the President's Emergency Plan for AIDS Relief (PEPFAR)

Agency: CGH

12/30/2102/28/22

Soroti Regional Mechanism for Reaching and Sustaining Epidemic Control in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR)

Agency: CGH

12/30/2102/28/22

Mubende Regional Mechanism for Reaching and Sustaining Epidemic Control in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR)

Agency: CGH

12/30/2102/28/22

Masaka Regional Mechanism for Reaching and Sustaining Epidemic Control in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR)

Agency: CGH

12/30/2102/28/22

Strengthening Sample Transportation System in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR)

Agency: CGH

12/30/2102/28/22

Kampala Regional Mechanism for Reaching and Sustaining Epidemic Control in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR)

Agency: CGH

12/30/2102/28/22

Health Promotion and Disease Prevention Research Centers: 2022 Special Interest Project Competitive Supplements (SIPS)

Agency: HHSCDCERA

12/23/2103/04/22

Transgender Status-Neutral Community-to-Clinic Models to End the HIV Epidemic

Agency: NCHHSTP

12/22/2102/25/22

Small Health Care Provider Quality Improvement Program

Agency: HRSA

12/21/2103/21/22

Enhanced Air Quality Monitoring for Communities

Agency: EPA

12/13/2102/25/22

Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNINRNCIODPOBSSRSGMROORWH

12/13/2105/07/25

High-Energy-Density Plasma Laboratory Science

Agency: SC

12/08/2102/07/22

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/23/2109/22/22

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/23/2109/22/22

Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/23/2111/17/24

Biomanufacturing: Survival, Utility, and Reliability beyond Earth (BSURE)

Agency: BTO

11/22/2101/25/22

Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNIDCRNIEHSNIMHNCIODPOBSSRSGMRO

11/20/2105/07/24

Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNEINHLBINHGRINIAAANIAIDNIAMSNIDCDNIDCRNIMHNINDSNCCIHNCIORWH

11/19/2104/18/24

Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNCCIHNCATSORIP

11/19/2102/02/24

Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNEINHLBINHGRINIAAANIAIDNIAMSNIDCDNIDCRNIMHNINDSNCCIHNCIORWH

11/19/2112/13/23

Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHD

11/17/2106/10/22

NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)

Agency: NIH

Institutions: NCI

11/05/2102/28/22

NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)

Agency: NIH

Institutions: NCI

11/03/2102/28/22

NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/03/2102/28/22

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/03/2109/22/22

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/03/2109/22/22

Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/03/2101/07/25

Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/03/2101/07/25

Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHD

11/01/2102/23/22

Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations

Agency: NCCDPHP

10/28/2101/26/22

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

10/21/2109/13/24

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

10/12/2110/08/24

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

10/12/2101/07/25

Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trial Required)

Agency: NIH

Institutions: OPPNETNIANIAAANIDANINRNCCIHNCI

10/05/2109/07/24

Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required)

Agency: NIH

Institutions: OPPNETNEINIANIAAANICHDNIDCRNIDANIMHNINDSNINRNIMHDNCIOBSSR

10/05/2106/21/24

Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: OPPNETNEINIANIAAANICHDNIDCRNIDANIMHNINDSNINRNIMHDNCCIHNCIOBSSR

10/05/2106/21/24

Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: FICNICHDNIDANIMHNCI

09/28/2112/20/22

The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

09/27/2112/15/23

INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODNEINHLBINIANIAIDNIAMSNICHDNIDCDNIDCRNCCIHORIPNCI

09/24/2111/03/22

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

09/22/2111/05/24

Development of Microbiome-Related Approaches for Diagnosis/Mitigation/Treatment of Radiation Injuries (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

09/20/2102/09/22

Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/16/2106/11/24

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

09/16/2106/11/24

NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)

Agency: NIH

Institutions: NCI

09/10/2109/07/24

NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/10/2109/07/24

NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/10/2109/07/24

NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required)

Agency: NIH

Institutions: NCI

09/10/2109/07/24

Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINICHDNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNIDCDNIDCRNIDANIDDKNIEHSNIGMSNIMHNINDSNINRNIMHDNCCIHNCATSNLMORIPNCIPCNCEHNIOSH

09/10/2109/09/24

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/08/2110/11/24

Emerging Global Leader Award (K43 Independent Clinical Trial Required)

Agency: NIH

Institutions: FICNCINHGRINIANIEHSNIMHNINDSORWH

09/08/2112/11/23

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: FICNCINHGRINIANIDCRNIEHSNIMHNINDSORWH

09/08/2112/11/23

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

09/03/2109/07/24

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/03/2109/07/24

Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/02/2109/07/24

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/02/2109/07/24

Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/02/2109/07/24

National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/01/2109/28/23

NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/31/2111/12/24

NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)

Agency: NIH

Institutions: NCI

08/31/2111/12/24

Fiscal Year 2022 Consolidated Innovative Nuclear Research

Agency: ID

08/30/2102/23/22

Ecology and Evolution of Infectious Diseases

Agency: NSF

08/27/2111/16/22

Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/26/2109/07/24

Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/26/2109/07/24

Reproducible Cells and Organoids via Directed- Differentiation Encoding

Agency: NSF

08/24/2103/31/22

NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/20/2110/06/23

Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNICHDNCIODP

08/11/2109/10/24

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)

Agency: NIH

Institutions: FICNEINIBIBNICHDNIDCDNIEHSNIMHNCIOBSSRORWH

08/04/2112/09/22

2021 Human Exploration Research Opportunities (HERO)

Agency: JSC

07/30/2107/29/22

Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

07/28/2110/19/22

Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDA

07/22/2102/17/22

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

07/22/2109/07/24

Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

07/22/2109/07/24

Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

07/12/2110/06/22

Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)

Agency: NIH

Institutions: NHGRINCINIAID

07/12/2106/15/23

Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: OPPNETNIANIAAANICHDNIDCRNIDANIMHNIMHDNCIOBSSRSGMROORWH

07/09/2105/07/23

Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans)

Agency: NIH

Institutions: OPPNETNIANIAAANICHDNIDCRNIDANIMHNIMHDNCIOBSSRSGMROORWH

07/09/2105/07/23

PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIPNCI

07/08/2104/05/22

PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIPNCI

07/08/2104/05/22

PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)

Agency: NIH

Institutions: ODNEINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDANIEHSNIGMSNIMHNINRNIMHDNCCIHNCATSNCI

07/08/2104/05/22

PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)

Agency: NIH

Institutions: ODNEINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNIMHDNCCIHNCI

07/08/2104/05/22

Exploiting in Vivo or in Situ Imaging Approaches to Understand HIV-relevant Processes In The Context of Substance Use Disorders (R61/R33 Clinical Trials Optional)

Agency: NIH

Institutions: NIDA

07/08/2108/11/22

HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)

Agency: NIH

Institutions: FICNIAMSNIDDKNIDANIMHNCI

07/06/2112/08/22

Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNIAIDNIDCRNIEHSNCI

07/06/2110/19/23

Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSNIBIBORIPODPOBSSRODSORWHOD

06/30/2106/30/24

The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)

Agency: NIH

Institutions: NIMHDNIANIDANIEHSNIMHNCISGMROORWH

06/25/2109/07/24

Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

06/03/2112/01/24

Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required)

Agency: NIH

Institutions: NIDANEINHGRINIANIAAANICHDNIDCDNIMHNINDSNINRNCI

05/19/2105/07/24

Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIGMSNEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNINDSNINRNLMNCCIHNCI

05/19/2105/07/24

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINIDCR

03/25/2101/07/24

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

03/25/2101/07/24

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

03/18/2111/17/23

Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIGMSNEINHGRINIANIAAANIAIDNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNINDSNINRNCI

03/18/2101/07/24

Research on Bat Immunology (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

03/18/2103/15/22

The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required)

Agency: NIH

Institutions: NCI

03/15/2103/14/24

The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required)

Agency: NIH

Institutions: NCI

03/15/2103/14/24

The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

03/15/2103/14/24

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

03/12/2103/07/24

HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNEINIANIAAANIAMSNICHDNIDCRNIMHNCATSNCCIH

03/11/2110/10/23

Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINHLBINIAAANIDANIEHSCTPODP

03/10/2103/08/23

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNIMHDNLMNCCIHNCATSORIPNCI

02/10/2101/07/24

Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed)

Agency: NIH

Institutions: ORIP

01/08/2101/07/24

Cyber-Physical Systems

Agency: NSF

01/08/2106/15/22

International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed

Agency: NIH

Institutions: FICNCI

01/04/2103/08/23

International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required)

Agency: NIH

Institutions: FICNCI

01/04/2103/08/23

Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINDSNEINIANIAAANIDCRNIDANIMHNINRNIMHDNCCIHNCIOBSSR

12/23/2002/05/23

Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIANIAMSNIDCRNIDDKNIMHNINDSNCI

11/23/2001/07/24

Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NIANIAMSNIDCRNIDDKNINDSNCI

11/23/2001/07/24

Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science

Agency: NSF

11/20/2011/10/22

Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNIAAANIEHSNCIOBSSR

11/17/2001/07/23

Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed)

Agency: NIH

Institutions: NIMHDNIANIAAANIEHSNCI

11/17/2001/07/23

Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/17/2001/07/24

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPSGMRO

11/16/2005/07/23

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Agency: NIH

Institutions: NCI

11/12/2001/07/24

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Agency: NIH

Institutions: NCI

11/10/2001/07/24

Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINCCIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNIMHDNINDSNINRNLMORIPORWH

11/09/2012/28/23

Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required)

Agency: NIH

Institutions: NCINCCIHNEINIANIAAANIAMSNICHDNIDCDNIDCRNIDANIEHSNIMHNIMHDNINDSNINRNLMORWH

11/09/2012/28/23

Limited Competition: Lasker Clinical Research Scholars Transition Award (R00 Clinical Trial Optional)

Agency: NIH

Institutions: NCINHLBINIAAANIAIDNIDDK

11/05/2009/30/23

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)

Agency: NIH

Institutions: NCCIHNCINEINHGRINHLBINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDNINRNINDSNLMORIPNIDANIBIBNIGMS

10/28/2009/07/23

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)

Agency: NIH

Institutions: NCCIHNCINEINHGRINHLBINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIEHSNIGMSNIMH

10/26/2009/07/23

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)

Agency: NIH

Institutions: NCCIHNCINEINHLBINIANIAAANIAIDNICHDNIDCDNIDCRNIDDKNIEHSNIMHORIP

10/26/2009/07/23

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)

Agency: NIH

Institutions: NCCIHNCINHLBINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNINDSNLMORIP

10/26/2012/08/23

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)

Agency: NIH

Institutions: NCCIHNCINEINHGRINHLBINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDNINRNINDSNLMORIP

10/21/2009/07/23

University Nuclear Leadership Program– Scholarship and Fellowship Support

Agency: ID

10/15/2010/14/30

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPODPOBSSRODSORWH

10/13/2010/07/23

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

10/13/2010/10/23

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

10/13/2010/10/23

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required)

Agency: NIH

Institutions: NCINIDCR

09/28/2001/07/24

Department of Defense HIV/AIDS Prevention Program

Agency: AMRAA

09/24/2009/23/22

Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)

Agency: NIH

Institutions: NCIODP

09/15/2001/18/22

Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCIODP

09/04/2009/07/23

Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCIODP

09/04/2009/07/23

NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/24/2007/20/22

Research to Improve Native American Health (R21 Clinical Trials Optional)

Agency: NIH

Institutions: NIDANIAAANIAMSNIDCRNIEHSNIMHNINRNIMHDNLMNCCIHNCATSNCIOBSSR

08/17/2009/07/23

Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANHLBINIAAANIAIDNIAMSNIBIBNIDCRNIEHSNIMHNINRNIMHDNLMNCIOBSSR

08/17/2009/07/23

Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/13/2005/04/23

Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/05/2011/09/22

Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODSNCINIDDKNIEHSNCCIH

07/30/2004/15/22

Ethical, Legal and Social Implications (ELSI) (Research R01 Clinical Trial Optional)

Agency: NIH

Institutions: NHGRINCINEINHLBINIANIEHSNIMHNIMHDNINDSOBSSR

07/28/2007/19/23

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21) (Clinical Trial Optional)

Agency: NIH

Institutions: NHGRINCINEINIANIEHSNIMHNINDSOBSSR

07/28/2007/19/23

Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03) Clinical Trial Optional)

Agency: NIH

Institutions: NHGRIFICNCINIANIEHSNIMHOBSSR

07/28/2007/19/23

Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNIEHSNCIODPORWH

07/23/2006/19/23

Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNIEHSNCIODPORWH

07/23/2006/19/23

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINHGRINIDCR

07/22/2009/07/22

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCINHGRINIDCR

07/22/2009/07/22

Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINIDCDNIMH

07/20/2001/07/23

Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NCCIHNIANIAAANIMHNCIOBSSR

07/15/2006/19/23

SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIBIBNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNLMNCCIHNCATS

07/10/2004/05/22

Administrative Supplement for Research on Dietary Supplements (Admin Supp-Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODSNCINEINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIEHSNIMHDFICNCCIHORIP

06/09/2004/15/23

Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required)

Agency: NIH

Institutions: OPPNETNIAAANIEHSNIMHNIMHDNCCIHNCIOBSSR

06/03/2003/17/23

Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials)

Agency: NIH

Institutions: OPPNETNIAAANIEHSNIMHNIMHDNCCIHNCIOBSSR

06/03/2003/17/23

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

Agency: NIH

Institutions: NCCIHODS

05/20/2005/07/23

NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)

Agency: NIH

Institutions: NCCIH

05/20/2005/07/23

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)

Agency: NIH

Institutions: NCCIHNCINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDCRNIDANIMHNINDSNIEHSNIMHD

05/12/2005/07/23

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)

Agency: NIH

05/12/2005/07/23

NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIHNEINHGRINIANIAAANIAIDNIAMSNIDCDNIDCRNIDANIEHSNINRNIMHDNLMNCCIHNCIICs

05/07/2005/07/23

NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)

Agency: NIH

Institutions: NCINHLBINHGRINIANIAAANIAMSNIBIBNICHDNIDANCCIHNIDDKNIEHSNIMHNINDSNINRNIMHD

05/05/2005/07/23

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIPNCIICs

05/05/2005/07/23

NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required)

Agency: NIH

Institutions: NCINEINIANIAAANICHDNIDCDNIDCRNIDANIEHSNIMHNIMHDNINDSNINRNCCIH

05/05/2005/07/23

NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIAIDNIBIBNCCIHNICHDNIDANIDCDNIDCRNIDDKNIEHSNIGMSNIMHNINDSNINRNLMORIPNIMHD

05/05/2005/07/23

Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional)

Agency: NIH

Institutions: ODPNIANIDCDNIDANIMHNINRNIMHDNCCIHNCIOBSSR

04/30/2009/07/23

Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional)

Agency: NIH

Institutions: ODPNIANIDCDNIDCRNCCIHNCI

04/30/2009/07/23

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNIANIDANCI

04/20/2009/07/23

New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

04/15/2006/06/23

Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNHLBINIANIAAANINDSNCI

04/03/2007/14/22

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIBIBNIDCR

03/30/2009/07/22

NIDA Small Research Grant Program (R03 Clinical Trial Required)

Agency: NIH

Institutions: NIDA

03/24/2005/07/23

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

Agency: NIH

Institutions: NCINEINHGRINHLBINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNCCIHORIP

03/20/2005/25/23

Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

03/12/2005/07/23

Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)

Agency: NIH

Institutions: NCINCCIHNHGRINIAIDNICHDNIDDKNIEHSNIGMSNIMH

03/10/2009/07/25

Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAIDNCINHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFIC

02/03/2007/28/22

Centers for AIDS Research (P30 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAIDNCINHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFIC

02/03/2007/28/22

National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/27/2005/07/23

Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNEINIMHNINDSNCI

01/23/2005/26/22

Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed)

Agency: NIH

Institutions: NIGMSNIAAANIAIDNIDANIEHSNINDSNIMHDNCI

01/17/2005/08/23

Biomedical Data Repository (U24 - Clinical Trials Not Allowed)

Agency: NIH

Institutions: NIGMSNIAAANIAIDNIDANIEHSNINDSNIMHDNCI

01/17/2005/08/23

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCI

01/14/2004/01/22

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCI

01/14/2004/01/22

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/10/1910/28/22

NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

12/09/1909/07/22

Co-infection and Cancer (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/22/1901/07/23

Co-infection and Cancer (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/22/1901/07/23

NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

11/22/1901/07/23

Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/12/1901/07/23

NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/08/1901/07/23

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/04/1910/12/21

Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

10/18/1901/07/23

Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCI

10/18/1911/07/22

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIGMSNIMHNINRNIMHDNLMNCCIHNCATSORIPNCI

10/04/1909/08/22

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)

Agency: NIH

Institutions: NINDSNEINHLBINIANIAAANIBIBNICHDNIDDKNIGMSNIMHNINRNIMHDNCCIHNCI

10/04/1909/08/22

HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)

Agency: NIH

Institutions: NINDSNEINHLBINIANIAAANIBIBNICHDNIDDKNIGMSNIMHNINRNIMHDNCCIHNCI

10/04/1909/08/22

HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIGMSNIMHNINRNIMHDNLMNCCIHNCATSORIPNCI

10/04/1909/08/22

Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

10/02/1901/07/23

Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIBIB

10/02/1901/07/23

Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNHLBINIDCRNCI

09/12/1901/07/23

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1907/16/22

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1909/07/22

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1909/07/22

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1909/07/22

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1909/07/22

Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/29/1903/11/22

Neural Regulation of Cancer (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/28/1905/27/22

Neural Regulation of Cancer (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/28/1905/27/22

Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/16/1906/08/22

Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/16/1906/08/22

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/12/1906/08/22

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/12/1906/08/22

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

07/30/1902/11/22

Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

06/28/1909/07/22

Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIA

06/25/1907/16/22

Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIA

06/25/1907/16/22

Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/22/1901/28/22

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINHGRINIANIAAANICHDNIDCRNIDANIEHSNIMHNINDSFICODPOBSSRORWH

05/08/1905/07/22

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINHLBINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNIMHDNCCIHODPOBSSRORWH

05/08/1905/07/22

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINHGRINIANIAAANIAIDNIAMSNIDCDNIDANIEHSNIMHNINDSNINRFICNCCIHODPOBSSRORWH

05/08/1905/07/22

Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCCIHNCINIANIAAANIDANIDCRNINDSNINROBSSRORWH

02/28/1905/07/22

Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCCIHNCINHLBINIANIAAANIDANIDCRNINDSNINROBSSRORWH

02/28/1905/07/22

Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/22/1905/07/22

Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/22/1905/07/22

Biology of Bladder Cancer (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/05/1905/07/22

Biology of Bladder Cancer (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/05/1905/07/22

Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIBIBNIAAANIAMSNCINIDCRNIEHSNINDSNIANEI

01/08/1905/07/22

Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)

Agency: NIH

Institutions: NIBIBNCINIANIAAANINDSNEI

01/08/1905/07/22

Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIANIAAANIDCRNIDANIMHNIMHD

09/21/1805/07/22

Fundamental Research to Counter Weapons of Mass Destruction

Agency: DTRA

03/20/1509/30/24
  TOP